Pioneering CAR-T Cell Therapy: Advancing Personalized Cancer TreatmentEmily Whitehead, diagnosed with relapsed acute lymphoblastic leukemia (ALL), was the first child to receive CAR-T therapy in 2012 after all standard treatments failed. The CAR-T cell therapy worked on Emily, and she is c...
Detailed information

EDNRA: A Key Target for Disease-Associated Angioplasty, Tumor Invasion, and Metabolic Regulation1. About EDNRA Endothelin A receptor (Endothelin Receptor Type A, EDNRA), a member of the G protein-coupled receptor (GPCR) family, is mainly expressed in endothelial and smooth muscle cells an...
Detailed information

DLL4: A Key Target for Angiogenesis RegulationRecently, Co.unlink Medicines and Compass Therapeutics announced that the phase II/III clinical trials of the VEGF/DLL4 bispecific antibody tovecimig (CTX-009/ES104) for second-line cholangiocarcinoma treatment have reac...
Detailed information

Decoding Recombinant Protein Expression: Strategic Solutions & Practical InsightsRecombinant protein expression is a cornerstone of biotechnology. It powers drug development, studies in structural biology, and enzyme production. But let’s be honest, how many times have you stared at a gel showing n...
Detailed information

CEACAM1: An Emerging Multifunctional Target for Cancer-Immune ModulationCarcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1), also known as CD66a or Biliary Glycoprotein (BGP), belongs to the immunoglobulin superfamily and is widely present in various cells. It has multiple bi...
Detailed information

MSTN: A Key Target for Targeted Therapy in Muscle Diseases​Recently, Keros Therapeutics, Inc. announced positive results from the Phase I clinical trial of KER-065 in patients with Duchenne muscular dystrophy, which for the first time confirmed its safety in patients with neurom...
Detailed information

How the Tumor Microenvironment Fuels Cancer's Deadly EvolutionCancer is not an isolated collection of mutated cells. It exists and evolves within a highly dynamic and interactive ecosystem known as the tumor microenvironment (TME). The TME surrounds and sustains tumors, playing a c...
Detailed information

PVR (CD155): A Key Factor in Tumor Immune Evasion and a Novel Therapeutic Target1. Background and Basic Functions of PVR PVR (CD155), a member of the immunoglobulin superfamily, is a cell surface glycoprotein initially identified as the receptor for poliovirus, hence its n...
Detailed information

TNFRSF13C (BAFF-R): A Key Target for Immune Regulation and Disease TreatmentTNFRSF13C (BAFF-R), a member of the TNF receptor superfamily, is pivotal for immune regulation. This review delves into its background, mechanisms, signaling pathways, associated diseases, and drug development progress. ...
Detailed information

How to Choose the Right Recombinant Protein for Your Experimental Model?Recombinant proteins play a critical role in modern biological research, with increasingly extensive applications ranging from basic studies and disease modeling to drug research and development. The ability to produce a...
Detailed information